- Home
- PETS vs IAF Comparison
PETS vs IAF Comparison
Compare PETS & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETS
- IAF
- Stock Information
- Founded
- PETS 1996
- IAF 1985
- Country
- PETS United States
- IAF United States
- Employees
- PETS N/A
- IAF N/A
- Industry
- PETS Retail-Drug Stores and Proprietary Stores
- IAF Finance/Investors Services
- Sector
- PETS Consumer Staples
- IAF Finance
- Exchange
- PETS Nasdaq
- IAF Nasdaq
- Market Cap
- PETS 98.6M
- IAF 113.8M
- IPO Year
- PETS N/A
- IAF N/A
- Fundamental
- Price
- PETS $5.11
- IAF $4.36
- Analyst Decision
- PETS Sell
- IAF
- Analyst Count
- PETS 2
- IAF 0
- Target Price
- PETS $3.50
- IAF N/A
- AVG Volume (30 Days)
- PETS 249.5K
- IAF 90.4K
- Earning Date
- PETS 02-06-2025
- IAF 01-01-0001
- Dividend Yield
- PETS N/A
- IAF 11.44%
- EPS Growth
- PETS N/A
- IAF N/A
- EPS
- PETS N/A
- IAF N/A
- Revenue
- PETS $259,343,000.00
- IAF N/A
- Revenue This Year
- PETS N/A
- IAF N/A
- Revenue Next Year
- PETS $3.36
- IAF N/A
- P/E Ratio
- PETS N/A
- IAF N/A
- Revenue Growth
- PETS N/A
- IAF N/A
- 52 Week Low
- PETS $2.90
- IAF $3.60
- 52 Week High
- PETS $7.24
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- PETS 52.60
- IAF 52.96
- Support Level
- PETS $4.74
- IAF $4.22
- Resistance Level
- PETS $5.30
- IAF $4.39
- Average True Range (ATR)
- PETS 0.24
- IAF 0.05
- MACD
- PETS 0.02
- IAF 0.02
- Stochastic Oscillator
- PETS 65.06
- IAF 86.36
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.